Klar Sehen Pvt Ltd - Due diligence report

A 360° intelligence report on Vivimedlabs: trust score, financial health, credit view, compliance, directors, growth and distress signals - …

1977-08-11 Bidar, Karnataka Amalgamated Unlisted
Share
View plans
KS Klar Sehen Pvt Ltd
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Vivimedlabs — 360° Intelligence Report

Generated from MCA filings & public records
61/100
Trust Score
Moderate

Vivimedlabs is assessed as Moderate with a Trust Score of 61/100. Vivimedlabs is a private limited indian non-government company incorporated in 1977, operating in the Pharma sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.

Report generated on 27 Jun 2026 from the latest processed filings. Klar Sehen Pvt Ltd snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
61/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
5/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 1 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 3 satisfied (12.88 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Axis Bank Limited1 48.0 cr
State Bank Of Hyderabad1 48.0 cr
Uco Bank1 48.0 cr
Compliance Score: 5/100 Caution Indicated
  • Company status is "Amalgamated" - not Active.
  • Last balance sheet is for Mar 2016 - filings overdue.
  • Flagged by authority: EPFO.
  • Litigation present in 3 court forum(s).
Legal cases on record (3)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
SANDEEP VARALWAR 01234567 Director 01/04/2018 6 yrs Approved
RAMESH CHALLA 01234567 Director 01/04/2018 6 yrs Approved
SANTOSH VARALWAR 01234567 Director 01/04/2018 6 yrs Approved
MANOHAR RAO VARALWAR 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2016 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Vivimed Labs Limited
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Vivimed Labs Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 55
Growth signals & trust indicators
Operating for 48+ years.
Active EPFO - real payroll on record.
Distress signals & risk flags
Statutory filings appear overdue.
Adverse company status: Amalgamated.
Compliance score is weak (5/100).
3 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence37/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment71/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view47/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2016
Last AGM held
Annual general meeting
31 Mar 2016
Latest balance sheet
Filed with ROC
29 Jun 2015
Director ceased
ASHIS KUMAR LAHIRI
25 Feb 2015
Charge satisfied
State Bank Of Hyderabad
17 Oct 2014
Charge satisfied
Axis Bank Limited
25 Sep 2014
Charge created
State Bank Of Hyderabad - 5.75 cr
30 Jul 2013
Charge created
Axis Bank Limited - 6.50 cr
Charge satisfied
Uco Bank
29 Sep 2011
Director appointed
SANDEEP VARALWAR (Director)
Director appointed
RAMESH CHALLA (Director)
Director appointed
SANTOSH VARALWAR (Director)
Director appointed
MANOHAR RAO VARALWAR (Director)
Director ceased
ANUP SANKAR BHADURI
Director ceased
RUNU BHADURI
23 May 1978
Charge created
Uco Bank - 63.25 Lakh
10

Key Observations

Auto-generated from the data above
4 active director(s) / partner(s); board looks stable and experienced.
All 3 registered charge(s) stand satisfied - past borrowings repaid.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2016 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Rosevalley Polymers Private Limited U99999HR1998PTC033850 Haryana, Haryana, India
Roha Carbonates Private Limited U24100MH2009PTC192915 Mumbai, Maharashtra, India
Dimple Chemicals & Services Private Limited U24119PN2008PTC133208 Pune, Maharashtra, India
Jaimurty Minerals And Chemicals Private Limited U24111UR1983PTC006328 Uttaranchal, Uttarakhand, India
Lasalabs U24100MH1986PTC040668 Badlapur, Maharashtra, India
Illusiondentallab U51397MH2004PTC149050 Mumbai, Maharashtra, India
Borax Morarji Limited L24100MH1963PLC012706 Mumbai, Maharashtra, India
Sainor Pharma Private Limited U24239TG2004PTC042653 Hyderabad, Telangana, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Vivimedlabs before audits and certifications: compliance score 5/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Vivimedlabs: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score n/a, margin trends, ownership structure and peer set for Vivimedlabs - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 61/100, distress signals and MSME payment-delay disclosures - know whether Vivimedlabs pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Vivimedlabs - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Vivimedlabs an active company?

Vivimedlabs has MCA status “Amalgamated” with a compliance score of 5/100 (Caution Indicated).

Is Vivimedlabs financially healthy?

Vivimedlabs has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.

Should I do business with Vivimedlabs?

Its overall Trust Score is 61/100 (Moderate). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Vivimedlabs?

The ultimate holding entity is Vivimed Labs Limited. 4 active director(s) are on record.

Does Vivimedlabs have loans or charges against its assets?

No open charges - all 3 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Vivimedlabs up to date with its ROC filings?

Last balance sheet is for Mar 2016 - filings overdue. Overall compliance score: 5/100 (Caution Indicated).

Is it risky to lend to Vivimedlabs?

Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.